As of May 18
| +0.13 / +0.17%|
The 8 analysts offering 12-month price forecasts for China Biologic Products Holdings Inc have a median target of 90.00, with a high estimate of 115.00 and a low estimate of 77.00. The median estimate represents a +14.16% increase from the last price of 78.84.
The current consensus among 8 polled investment analysts is to Buy stock in China Biologic Products Holdings Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.